Design, simulation, and optimization of a large-scale monoclonal antibody production plant: Upstream design

Pharmaceutical Engineering

Volumn 24, Issue 6, 2004, Pages 42-60

  Oh, Steve K W ^a,b,c,d,e   Kuek, K H ^e,f   Wong, Victor V T ^a,e,g  

^a AGENCY FOR SCIENCE   (Singapore)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d Pall Corp   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f SINGAPORE MIT ALLIANCE   (Singapore)

^g UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; MONOCLONAL ANTIBODY; RITUXIMAB;

ANIMAL CELL; ARTICLE; BIOREACTOR; COMPUTER PROGRAM; EQUIPMENT; FEASIBILITY STUDY; MOUSE; NONHUMAN; PLANNING; PROCESS DESIGN; PROCESS MODEL;

EID: 10644266765     PISSN: 02738139     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Carter, P., "Improving the Efficacy of Antibody-based Cancer Therapies," Nature Rev., Vol. 1, 2001, pp. 118-129.
2. Petrides, Demitri P., Alexandros Koulouris, and Pericles T. Lagonikos, "The Role of Process Simulation in Pharmaceutical Process Development and Product Commercialization," Pharmaceutical Engineering, Vol. 22, No. 1, January/February 2002, pp. 56-65.
3. Follstad, B.D., R.R. Balcarcel, G. Stephanopoulos, and D.I.C. Wang, "Metabolic Flux Analysis of Hybridoma Continuous Culture Steady State Multiplicity," Biotechnol. Bioeng., Vol. 63, 1999, pp. 675-683.
4. nd Ed. New York: McGraw-Hill, 1986, p. 42-46.
5. Sandstrom, C.E., J.G. Bender, W.M. Miller, and E.T. Papoutsakis, "Development of Novel Perfusion Chamber to Retain Nonadherent Cells and Its Use for Comparison of Human 'Mobilized' Peripheral Blood Mononuclear Cell Cultures with and without Irradiated Bone Marrow Stroma," Biotechnol. Bioeng., Vol. 50, 1996, pp. 493-504.
6. Xie, L.Z. and D.I.C. Wang, "Stoichiometric Analysis of Animal-Cell Growth and Its Application in Medium Design," Biotechnol. Bioeng., Vol. 43, 1994, pp. 1164-1174.
7. SuperPro Designer User's Guide, Intelligen, Inc., Scotch Plains, NJ, 2002.
8. Antibody Production, Genetic Engineering News, 22, 2002.
9. Walter, P.K., Process Design and Economics for Large Scale Monoclonal Antibody Manufacturing, IBC's 8th International Antibody Production and Downstream Processing, IBC USA International Conference, 2002.
10. Mallik, A., G.S. Pinkus, and S. Sheffer, "Biopharma's Capacity Crunch," in the McKinsey Quarterly, Special Edition: Risk and Resilience, 2002.
11. Yuk, H.Y., S. Wildt, M. Jolicoeur, D. I. C. Wang, and G. Stephanopoulos, "A GFP-Based Screen for Growth-Arrested, Recombinant Protein-Producing Cells," Biotechnol.Bioeng., Vol. 79, 2002, pp. 74-82.
12. Lee, J.H., H.C. Lim, Y.J. Yoo, and Y.H. Park, "Optimization of Feed Rate Profile for Monoclonal Antibody Production," Bioprocess Engineering, Vol. 20, 1999, pp. 137-146.
13. Bibila, T.A. and O.K. Robinson, "In Pursuit of the Optimal Fed-Batch Process for Monoclonal Antibody Production," Biotechnol. Prog., Vol. 11, 1995, pp. 1-13.
14. Jo, E.G., H.J. Park, D.I. Kim and H.M. Moon, "Repeated Fed-Batch Culture of Hybridoma Cells in Nutrient-Fortified High-Density Medium," Biotechnol. Bioeng., Vol. 42, 1993, pp. 1229-1237.
15. Shanklin, T., Roper, K., Yegneswaran, P.K. and Marten, M.R., "Selection of Bioprocess Simulation Software for Industrial Applications," Biotechnol. Bioeng., Vol. 72, 2001, pp. 483-489.
16. Rouf, S.A., Douglas, P.L., Moo-Young, M., and Scharer, J.M., "Computer Simulation for Large Scale Bioprocess Design," Biochem. Eng. Journal, Vol. 8, 2001, pp. 229-234.